34.98 USD
+0.77 (+2.25%)
At close: Feb 6, 2026
34.98 USD
0 (0%)
After Hours: 2/6/2026, 8:00:01 PM
Taking everything into account, IBEX scores 7 out of 10 in our fundamental rating. IBEX was compared to 88 industry peers in the IT Services industry. IBEX has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. An interesting combination arises when we look at growth and value: IBEX is growing strongly while it also seems undervalued. These ratings could make IBEX a good candidate for value and growth and quality investing.
1. Profitability
1.1 Basic Checks
- In the past year IBEX was profitable.
- IBEX had a positive operating cash flow in the past year.
- Each year in the past 5 years IBEX has been profitable.
- In the past 5 years IBEX always reported a positive cash flow from operatings.
1.2 Ratios
- IBEX has a Return On Assets of 14.58%. This is amongst the best in the industry. IBEX outperforms 93.18% of its industry peers.
- IBEX has a Return On Equity of 28.81%. This is amongst the best in the industry. IBEX outperforms 89.77% of its industry peers.
- The Return On Invested Capital of IBEX (21.63%) is better than 94.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.58% | ||
| ROE | 28.81% | ||
| ROIC | 21.63% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Profit Margin, with a value of 7.14%, IBEX is in the better half of the industry, outperforming 73.86% of the companies in the same industry.
- IBEX's Profit Margin has improved in the last couple of years.
- IBEX has a better Operating Margin (9.18%) than 68.18% of its industry peers.
- In the last couple of years the Operating Margin of IBEX has grown nicely.
- IBEX has a Gross Margin (30.62%) which is in line with its industry peers.
- In the last couple of years the Gross Margin of IBEX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.18% | ||
| PM (TTM) | 7.14% | ||
| GM | 30.62% |
OM growth 3Y27.75%
OM growth 5Y12.6%
PM growth 3Y14.82%
PM growth 5Y27.95%
GM growth 3Y0.55%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IBEX is creating value.
- There is no outstanding debt for IBEX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- IBEX has an Altman-Z score of 5.11. This indicates that IBEX is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of IBEX (5.11) is better than 81.82% of its industry peers.
- IBEX has a debt to FCF ratio of 0.05. This is a very positive value and a sign of high solvency as it would only need 0.05 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 0.05, IBEX belongs to the top of the industry, outperforming 93.18% of the companies in the same industry.
- IBEX has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
- IBEX has a better Debt to Equity ratio (0.01) than 84.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.05 | ||
| Altman-Z | 5.11 |
ROIC/WACC2.29
WACC9.43%
2.3 Liquidity
- IBEX has a Current Ratio of 1.82. This is a normal value and indicates that IBEX is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of IBEX (1.82) is comparable to the rest of the industry.
- IBEX has a Quick Ratio of 1.82. This is a normal value and indicates that IBEX is financially healthy and should not expect problems in meeting its short term obligations.
- IBEX has a Quick ratio of 1.82. This is comparable to the rest of the industry: IBEX outperforms 56.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.82 |
3. Growth
3.1 Past
- IBEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.77%, which is quite impressive.
- Measured over the past years, IBEX shows a very strong growth in Earnings Per Share. The EPS has been growing by 41.04% on average per year.
- IBEX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.77%.
- IBEX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.62% yearly.
EPS 1Y (TTM)44.77%
EPS 3Y28.16%
EPS 5Y41.04%
EPS Q2Q%47.46%
Revenue 1Y (TTM)9.77%
Revenue growth 3Y4.24%
Revenue growth 5Y6.62%
Sales Q2Q%16.73%
3.2 Future
- IBEX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.72% yearly.
- IBEX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.19% yearly.
EPS Next Y22.95%
EPS Next 2Y13.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.81%
Revenue Next 2Y9.19%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 10.11, the valuation of IBEX can be described as reasonable.
- IBEX's Price/Earnings ratio is rather cheap when compared to the industry. IBEX is cheaper than 87.50% of the companies in the same industry.
- IBEX is valuated cheaply when we compare the Price/Earnings ratio to 27.92, which is the current average of the S&P500 Index.
- The Price/Forward Earnings ratio is 9.66, which indicates a very decent valuation of IBEX.
- Based on the Price/Forward Earnings ratio, IBEX is valued cheaper than 84.09% of the companies in the same industry.
- IBEX is valuated cheaply when we compare the Price/Forward Earnings ratio to 27.78, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.11 | ||
| Fwd PE | 9.66 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IBEX indicates a rather cheap valuation: IBEX is cheaper than 88.64% of the companies listed in the same industry.
- Based on the Price/Free Cash Flow ratio, IBEX is valued a bit cheaper than the industry average as 70.45% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.11 | ||
| EV/EBITDA | 6.24 |
4.3 Compensation for Growth
- IBEX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The decent profitability rating of IBEX may justify a higher PE ratio.
- IBEX's earnings are expected to grow with 13.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.44
PEG (5Y)0.25
EPS Next 2Y13.72%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- No dividends for IBEX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
34.98
+0.77 (+2.25%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)02-05 2026-02-05/amc
Earnings (Next)05-06 2026-05-06/amc
Inst Owners94.08%
Inst Owner Change-0.28%
Ins Owners2.8%
Ins Owner Change0.29%
Market Cap471.18M
Revenue(TTM)558.27M
Net Income(TTM)41.38M
Analysts45.71
Price Target41.82 (19.55%)
Short Float %0.81%
Short Ratio1.09
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.95%
Min EPS beat(2)20.05%
Max EPS beat(2)21.85%
EPS beat(4)4
Avg EPS beat(4)16.83%
Min EPS beat(4)10.89%
Max EPS beat(4)21.85%
EPS beat(8)7
Avg EPS beat(8)12.58%
EPS beat(12)10
Avg EPS beat(12)14.59%
EPS beat(16)12
Avg EPS beat(16)13.3%
Revenue beat(2)2
Avg Revenue beat(2)5.51%
Min Revenue beat(2)2.5%
Max Revenue beat(2)8.52%
Revenue beat(4)4
Avg Revenue beat(4)4.65%
Min Revenue beat(4)2.45%
Max Revenue beat(4)8.52%
Revenue beat(8)5
Avg Revenue beat(8)1.79%
Revenue beat(12)5
Avg Revenue beat(12)-0.35%
Revenue beat(16)7
Avg Revenue beat(16)-0.06%
PT rev (1m)0%
PT rev (3m)6.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.26%
EPS NY rev (1m)0%
EPS NY rev (3m)5.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.94%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.82%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.11 | ||
| Fwd PE | 9.66 | ||
| P/S | 0.81 | ||
| P/FCF | 15.11 | ||
| P/OCF | 8.79 | ||
| P/B | 3.28 | ||
| P/tB | 3.58 | ||
| EV/EBITDA | 6.24 |
EPS(TTM)3.46
EY9.89%
EPS(NY)3.62
Fwd EY10.35%
FCF(TTM)2.32
FCFY6.62%
OCF(TTM)3.98
OCFY11.37%
SpS43.04
BVpS10.66
TBVpS9.78
PEG (NY)0.44
PEG (5Y)0.25
Graham Number28.81
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.58% | ||
| ROE | 28.81% | ||
| ROCE | 26.64% | ||
| ROIC | 21.63% | ||
| ROICexc | 24.4% | ||
| ROICexgc | 26.15% | ||
| OM | 9.18% | ||
| PM (TTM) | 7.14% | ||
| GM | 30.62% | ||
| FCFM | 5.38% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y27.75%
OM growth 5Y12.6%
PM growth 3Y14.82%
PM growth 5Y27.95%
GM growth 3Y0.55%
GM growth 5YN/A
F-Score8
Asset Turnover2.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.05 | ||
| Debt/EBITDA | 0.01 | ||
| Cap/Depr | 129.83% | ||
| Cap/Sales | 3.86% | ||
| Interest Coverage | 31.53 | ||
| Cash Conversion | 76.01% | ||
| Profit Quality | 75.39% | ||
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.82 | ||
| Altman-Z | 5.11 |
F-Score8
WACC9.43%
ROIC/WACC2.29
Cap/Depr(3y)83.97%
Cap/Depr(5y)108.52%
Cap/Sales(3y)2.89%
Cap/Sales(5y)3.72%
Profit Quality(3y)75.63%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.77%
EPS 3Y28.16%
EPS 5Y41.04%
EPS Q2Q%47.46%
EPS Next Y22.95%
EPS Next 2Y13.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.77%
Revenue growth 3Y4.24%
Revenue growth 5Y6.62%
Sales Q2Q%16.73%
Revenue Next Year12.81%
Revenue Next 2Y9.19%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y23.48%
EBIT growth 3Y33.16%
EBIT growth 5Y20.06%
EBIT Next Year68.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y13.26%
FCF growth 3Y24.66%
FCF growth 5Y-10.09%
OCF growth 1Y19.11%
OCF growth 3Y4.51%
OCF growth 5Y-2.46%
IBEX LTD / IBEX FAQ
Can you provide the ChartMill fundamental rating for IBEX LTD?
ChartMill assigns a fundamental rating of 7 / 10 to IBEX.
What is the valuation status for IBEX stock?
ChartMill assigns a valuation rating of 8 / 10 to IBEX LTD (IBEX). This can be considered as Undervalued.
What is the profitability of IBEX stock?
IBEX LTD (IBEX) has a profitability rating of 7 / 10.
What is the valuation of IBEX LTD based on its PE and PB ratios?
The Price/Earnings (PE) ratio for IBEX LTD (IBEX) is 10.11 and the Price/Book (PB) ratio is 3.28.
Is the dividend of IBEX LTD sustainable?
The dividend rating of IBEX LTD (IBEX) is 0 / 10 and the dividend payout ratio is 0%.